These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31580259)

  • 21. Cysteine is not a substrate but a specific modulator of human ASCT2 (SLC1A5) transporter.
    Scalise M; Pochini L; Pingitore P; Hedfalk K; Indiveri C
    FEBS Lett; 2015 Nov; 589(23):3617-23. PubMed ID: 26492990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting ASCT2-mediated glutamine metabolism inhibits proliferation and promotes apoptosis of pancreatic cancer cells.
    Wang W; Pan H; Ren F; Chen H; Ren P
    Biosci Rep; 2022 Mar; 42(3):. PubMed ID: 35237783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Target the human Alanine/Serine/Cysteine Transporter 2(ASCT2): Achievement and Future for Novel Cancer Therapy.
    Jiang H; Zhang N; Tang T; Feng F; Sun H; Qu W
    Pharmacol Res; 2020 Aug; 158():104844. PubMed ID: 32438035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting SLC1A5 blocks cell proliferation through inhibition of mTORC1 in arsenite-treated human uroepithelial cells.
    Li S; Zhou Q; Liu W; Fu Z; Zhao H; Xi S
    Toxicol Lett; 2021 Jul; 345():1-11. PubMed ID: 33781819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transient kinetics reveal the mechanism of competitive inhibition of the neutral amino acid transporter ASCT2.
    Dong Y; Wang J; Grewer C
    J Biol Chem; 2024 Jun; 300(6):107382. PubMed ID: 38763337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutamine addiction activates polyglutamine-based nanocarriers delivering therapeutic siRNAs to orthotopic lung tumor mediated by glutamine transporter SLC1A5.
    Wang C; Wu J; Wang Z; Yang Z; Li Z; Deng H; Li L; Peng X; Feng M
    Biomaterials; 2018 Nov; 183():77-92. PubMed ID: 30149232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Large scale production of the active human ASCT2 (SLC1A5) transporter in Pichia pastoris--functional and kinetic asymmetry revealed in proteoliposomes.
    Pingitore P; Pochini L; Scalise M; Galluccio M; Hedfalk K; Indiveri C
    Biochim Biophys Acta; 2013 Sep; 1828(9):2238-46. PubMed ID: 23756778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-affinity glutamate transporter GLAST/EAAT1 regulates cell surface expression of glutamine/neutral amino acid transporter ASCT2 in human fetal astrocytes.
    Gegelashvili M; Rodriguez-Kern A; Pirozhkova I; Zhang J; Sung L; Gegelashvili G
    Neurochem Int; 2006; 48(6-7):611-5. PubMed ID: 16516348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SLC1A5 Silencing Inhibits Esophageal Cancer Growth via Cell Cycle Arrest and Apoptosis.
    Lin J; Yang T; Peng Z; Xiao H; Jiang N; Zhang L; Ca D; Wu P; Pan Q
    Cell Physiol Biochem; 2018; 48(1):397. PubMed ID: 30071532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterizing unexpected interactions of a glutamine transporter inhibitor with members of the SLC1A transporter family.
    Freidman NJ; Briot C; Ryan RM
    J Biol Chem; 2022 Aug; 298(8):102178. PubMed ID: 35752361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ablation of the
    Bröer A; Gauthier-Coles G; Rahimi F; van Geldermalsen M; Dorsch D; Wegener A; Holst J; Bröer S
    J Biol Chem; 2019 Mar; 294(11):4012-4026. PubMed ID: 30635397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The involvement of sodium in the function of the human amino acid transporter ASCT2.
    Mazza T; Scalise M; Pappacoda G; Pochini L; Indiveri C
    FEBS Lett; 2021 Dec; 595(24):3030-3041. PubMed ID: 34741534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Role of ASCT2 (SLC1A5) in KRAS-Mutated Colorectal Cancer.
    Toda K; Nishikawa G; Iwamoto M; Itatani Y; Takahashi R; Sakai Y; Kawada K
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28749408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development.
    Wang Q; Hardie RA; Hoy AJ; van Geldermalsen M; Gao D; Fazli L; Sadowski MC; Balaban S; Schreuder M; Nagarajah R; Wong JJ; Metierre C; Pinello N; Otte NJ; Lehman ML; Gleave M; Nelson CC; Bailey CG; Ritchie W; Rasko JE; Holst J
    J Pathol; 2015 Jul; 236(3):278-89. PubMed ID: 25693838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2-Amino-4-bis(aryloxybenzyl)aminobutanoic acids: A novel scaffold for inhibition of ASCT2-mediated glutamine transport.
    Schulte ML; Khodadadi AB; Cuthbertson ML; Smith JA; Manning HC
    Bioorg Med Chem Lett; 2016 Feb; 26(3):1044-1047. PubMed ID: 26750251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1,25-Dihydroxyvitamin D inhibits glutamine metabolism in Harvey-ras transformed MCF10A human breast epithelial cell.
    Zhou X; Zheng W; Nagana Gowda GA; Raftery D; Donkin SS; Bequette B; Teegarden D
    J Steroid Biochem Mol Biol; 2016 Oct; 163():147-56. PubMed ID: 27154413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis.
    Lu H; Li X; Lu Y; Qiu S; Fan Z
    Cancer Lett; 2016 Oct; 381(1):23-30. PubMed ID: 27450723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells.
    Yoo HC; Park SJ; Nam M; Kang J; Kim K; Yeo JH; Kim JK; Heo Y; Lee HS; Lee MY; Lee CW; Kang JS; Kim YH; Lee J; Choi J; Hwang GS; Bang S; Han JM
    Cell Metab; 2020 Feb; 31(2):267-283.e12. PubMed ID: 31866442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor activity of mianserin (a tetracyclic antidepressant) primarily driven by the inhibition of SLC1A5-mediated glutamine transport.
    Duan Z; Zhou Z; Lu F; Zhang Y; Guo X; Gui C; Zhang H
    Invest New Drugs; 2022 Oct; 40(5):977-989. PubMed ID: 35834041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery and Synthesis of Hydroxy-l-Proline Blockers of the Neutral Amino Acid Transporters SLC1A4 (ASCT1) and SLC1A5 (ASCT2).
    Lyda BR; Leary GP; Farnsworth J; Seaver B; Silvius D; Kavanaugh MP; Esslinger CS; Natale NR
    Molecules; 2024 May; 29(10):. PubMed ID: 38792190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.